WHAT DOES EARLY DATA SHOW ABOUT the BENEFITS of TREATMENTS for COVID 19?
Paxlovid, the Pfizer medication developed to treat COVID 19, is of benefit to high-risk seniors, and probably other individuals with compromised immune systems. It appears to provide no protection to younger adults. These are the preliminary results of a large study in Israel, involving 109,000 patients
Read more